WORLD LEADERS IN DISTINGUISHING PLACEBO FROM ACTIVE IN MEDICAL FOODS AND LIVE THERAPEUTICS
Metanalysis and Benchmark on COVID & Microbiome Clinical Research
About the webinar
What can you expect of our webinars?
ON DEMAND WEBINAR | AVAILABLE NOW
Duration: 24 min
Abstract: Join Suszie Tyree, Medical Writer PhD at Atlantia Clinical Trials, on this overview on the microbiome and COVID metanalysis and benchmark. Opportunities and challenges tend to arise when a situation of change occurs. How has the COVID-19 crisis disrupted microbiome research and industry?
Three main implications can be identified: microbiome and COVID research, challenges, and opportunities in clinical research.
SUSZIE TYREE | Medical Writer at Atlantia Clinical Trials
Suszie Tyree is a Medical Writer for Atlantia Clinical Trials with a background in scientific research. Suszie received her Master’s degree from Otago University (New Zealand) studying the role of high-fat diet and dietary hormones on brain functions related to anxiety. Following that, Suszie gained her PhD from the University of Potsdam (Germany) in collaboration with the German Institute of Human Nutrition studying food choice behaviours and neural processing of taste information. Prior to joining the team at Atlantia, Suszie also spent three years as a Postdoctoral Research Fellow at Stanford University (California, USA). At Atlantia Suszie develops research protocols and ethics application documents for clinical trials testing food and microbiome-based products on a range of health measures including cognition, microbiome analysis, glucose-response, bone-health, etc. Suszie is also involved in developing clinical study reports to present findings from the studies carried out at Atlantia.